Scientists expose COPD patients to ozone to uncover Pollution's hidden impact

NCT ID NCT04669743

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how ozone, a common air pollutant, affects immune cells in the lungs of people with COPD. Researchers will expose 72 participants (including healthy non-smokers, smokers without COPD, and COPD patients) to ozone in a controlled chamber and track changes in their lung immune cells. The goal is to understand why pollution triggers COPD flare-ups, which could lead to better prevention strategies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ozone exposure
What this could lead to
If successful, this could help explain why air pollution worsens COPD symptoms, pointing toward new ways to prevent flare-ups.
What could go wrong
This is an early observational study with no treatment being tested. Results may not lead to direct patient benefits or apply to real-world pollution scenarios.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AIRWAY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • San Francisco VA Medical Center

    San Francisco, California, 94121, United States

  • University of California, San Francisco

    San Francisco, California, 94122, United States

  • Zuckerberg San Francisco General Hospital and Trauma Center

    San Francisco, California, 94110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.